share_log

Pfizer | 4: Statement of changes in beneficial ownership of securities-Officer BOURLA ALBERT

Pfizer | 4: Statement of changes in beneficial ownership of securities

輝瑞 | 4:持股變動聲明
SEC announcement ·  04/11 14:55
Moomoo AI 已提取核心訊息
Pfizer Inc. (PFE) Chairman & CEO Albert Bourla executed a transaction of non-derivative securities on April 10, 2024. The specific details of the transaction, including the number of shares, transaction price, and total value, were not disclosed in the announcement. Bourla's relationship with the company as Chairman & CEO places him in a position of significant influence, and such transactions are closely watched by investors for indications of executive confidence in the company's performance and outlook.
Pfizer Inc. (PFE) Chairman & CEO Albert Bourla executed a transaction of non-derivative securities on April 10, 2024. The specific details of the transaction, including the number of shares, transaction price, and total value, were not disclosed in the announcement. Bourla's relationship with the company as Chairman & CEO places him in a position of significant influence, and such transactions are closely watched by investors for indications of executive confidence in the company's performance and outlook.
輝瑞公司(PFE)董事長兼首席執行官阿爾伯特·布爾拉於2024年4月10日執行了一筆非衍生證券交易。公告中未披露該交易的具體細節,包括股票數量、交易價格和總價值。Bourla作爲董事長兼首席執行官與公司的關係使他處於重要的影響力,此類交易受到投資者的密切關注,以尋找高管對公司業績和前景充滿信心的跡象。
輝瑞公司(PFE)董事長兼首席執行官阿爾伯特·布爾拉於2024年4月10日執行了一筆非衍生證券交易。公告中未披露該交易的具體細節,包括股票數量、交易價格和總價值。Bourla作爲董事長兼首席執行官與公司的關係使他處於重要的影響力,此類交易受到投資者的密切關注,以尋找高管對公司業績和前景充滿信心的跡象。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息